Hana Pharm Co., Ltd. (KRX:293480)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,100
-280 (-2.70%)
Mar 3, 2026, 3:30 PM KST
-2.79%
Market Cap 179.51B
Revenue (ttm) 139.33B
Net Income (ttm) 24.30B
Shares Out 17.77M
EPS (ttm) 2,243.00
PE Ratio 4.50
Forward PE n/a
Dividend 510.00 (4.91%)
Ex-Dividend Date Dec 29, 2025
Volume 132,594
Average Volume 78,649
Open 10,300
Previous Close 10,380
Day's Range 10,080 - 10,350
52-Week Range 10,050 - 12,500
Beta 0.27
RSI 35.76
Earnings Date Nov 14, 2025

About Hana Pharm

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1996
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 293480
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.